TOPIC
/
company
Pfizer
+ FOLLOW
Pfizer
The latest news, analysis and opinion on Pfizer. In-depth analysis, industry insights and expert opinion.
SHOW FULL PROFILE
Chairman / President
Albert Bourla
CEO / Managing Director
Albert Bourla
CFO / Finance Director
Dave Denton
Industry
Pharmaceuticals
Website
pfizer.com
Headquarters address
235 East 42nd Street, New York, NY 10017, United States
Stock Code
NYSE:PFE
Year founded
1849
European Union
EU’s von der Leyen loses court case over secret Pfizer texts
Wednesday’s ruling is likely to affect how the EU’s executive arm treats text messages in the future.
15 May 2025 - 10:28AM
Biomedicine: Companies
Hong Kong residents reticent to get latest Covid-19 jab, Moderna survey finds
4 Dec 2024 - 8:22PM
Hong Kong healthcare and hospitals
Elderly Hongkongers can apply for Covid XBB variant vaccine starting Wednesday
12 Dec 2023 - 8:11PM
Hong Kong healthcare and hospitals
Hong Kong receives first batch of Covid XBB variant vaccines
Vaccination arrangements for the 100,000-jab batch manufactured by US drug firm Pfizer expected to be announced in December.
30 Nov 2023 - 8:10PM
5
Hong Kong healthcare and hospitals
Hong Kong’s private healthcare sector expected to offer RSV vaccine in December
British pharmaceutical company GSK beats Pfizer in race to offer vaccine that can protect elderly against common respiratory infection.
20 Nov 2023 - 5:29PM
Coronavirus US
Coronavirus: US FDA approves updated Covid-19 vaccines
The FDA decision opens the newest vaccines from Moderna and Pfizer and its partner BioNTech to most Americans even if they have never had a Covid vaccination.
12 Sep 2023 - 3:31AM
Advertisement
Advertisement
Advertisement
Singapore
She died 4 days after a Covid booster jab. Singapore paid her family US$169,000
Filipino Ontal Charlene Vargas died of myocarditis, or inflammation of the heart. A coroner ruled it was likely related to the vaccine she had received.
17 Apr 2023 - 9:10AM
6
Coronavirus China
China gives green light to 2 home-grown Covid-19 antiviral treatments
The approval comes during reprieve from tsunami of infections but another wave could be on the way after Lunar New Year migration.
30 Jan 2023 - 6:00PM
Science
Chinese drug matches Paxlovid in treating less severe Covid symptoms
Patients who took the Chinese pill, known as VV116, recovered after a median time of 4 days and it had fewer adverse effects compared with the Pfizer drug.
30 Dec 2022 - 10:13PM
videocam
4
Coronavirus pandemic
WHO pleased to see China ease strict zero-Covid policies
It’s important that governments listen ‘when the people are in pain,’ a top official said in wake of protests in the country over coronavirus restrictions.
3 Dec 2022 - 3:27AM
videocam
Coronavirus pandemic: All stories
What’s next for pandemic winner Pfizer and its US$28 billion war chest?
Pfizer’s Covid-19 vaccine saw the pharmaceutical company become the world’s most visible drug maker, but with its stock falling in 2022, success has left investors impatient for an encore.
5 Nov 2022 - 7:45PM
Coronavirus Hong Kong
Antiviral drugs cut risk of death in Covid-19 patients, Hong Kong study shows
Large-scale study shows positive effects of two drugs given early to patients still in the community.
31 Oct 2022 - 7:00AM
4
Coronavirus vaccine
Explainer
|
Are the new Omicron-focused boosters safe and effective?
FDA has authorised emergency use of Pfizer-BioNTech and Moderna boosters that target BA.4 and BA.5 variants of Omicron.
2 Sep 2022 - 4:22PM
videocam
14
Coronavirus pandemic
German government prepares roll-out of adapted Covid-19 vaccine
The vaccine is adapted to the BA.1 variant and Germany will receive about 14 million doses of the vaccines made by Pfizer/BioNTech and Moderna, subject to EU approval.
30 Aug 2022 - 8:19AM
Coronavirus vaccine
Moderna sues Pfizer and BioNTech, alleging they copied Covid-19 vaccine tech
Moderna has filed a lawsuit against the two pharmaceutical firms and said it was seeking damages for activities occurring after March 8 this year.
26 Aug 2022 - 10:35PM
videocam
Coronavirus pandemic
Joe Biden tests positive for Covid-19, has ‘very mild symptoms’
The 79-year-old president is fully vaccinated and twice boosted and had begun taking Pfizer’s anti-Covid pill Paxlovid – he will continue carrying out his full duties while isolating at the White House.
22 Jul 2022 - 4:57AM
videocam
79
Chinese coronavirus vaccines
Chinese mRNA booster fights Omicron 4 times better than Sinovac: study
AWcorna vaccine produced 4.4 times more Omicron antibodies than for those boosted with Sinovac, scientists behind clinical trial write in Cell Research journal.
17 Jun 2022 - 9:47PM
videocam
67
Advertisement
Advertisement
Advertisement
Coronavirus pandemic
Pfizer offers to sell medicines at cost to poorest countries
The US pharmaceutical giant currently holds patents for 23 drugs, including Comirnaty and Paxlovid, its Covid vaccine and oral treatment; this commitment will increase access to nearly 1.2 billion people, Pfizer chief said.
25 May 2022 - 6:39PM
Coronavirus pandemic
Experts worry over ‘booster fatigue’ amid hunt for new vaccine improvements
Despite success in preventing serious illness and death, there’s growing pressure to develop vaccines better at fending off milder infections on top of aggressive variants.
24 Apr 2022 - 9:47PM
videocam
6
Coronavirus pandemic
Taiwan says Covid-19 child vaccine talks held up over Chinese sales rights
Taiwan sales rights for the child version of the vaccine belong not to producer Pfizer but to BioNTech and its Chinese sales agent, Fosun Pharma.
18 Apr 2022 - 5:59PM
videocam
Chinese coronavirus vaccines
China approves trials of home-grown mRNA vaccines as cases surge
The approvals add CanSino and CSPC to the race among Chinese companies to use mRNA to fight the coronavirus, offering viable alternatives to the vaccines already in production by Pfizer and Moderna.
4 Apr 2022 - 6:19PM
videocam
55
Coronavirus Hong Kong
16,000 Hong Kong patients receive new oral anti-Covid drugs
Hospital Authority has bought antiviral drugs molnupiravir, made by US firm MSD, and Pfizer’s Paxlovid, with both having been administered to patients for two weeks.
26 Mar 2022 - 9:14PM
Fosun Group
Fosun sees profit rise, set to make generic Pfizer, Merck Covid-19 pills
Shanghai Fosun Pharmaceutical Group is looking into which of its existing plants can be used to manufacture generic versions of Pfizer’s nirmatrelvir, which is sold under the Paxlovid brand name, and Merck’s molnupiravir.
24 Mar 2022 - 6:20PM
videocam
Coronavirus Hong Kong
Coronavirus: nearly 10,000 Hongkongers treated with oral antivirals
Hospital Authority Chief Manager Dr Lau Ka-hin says public health facilities have administered MSD’s molnupiravir to 8,500 patients so far.
23 Mar 2022 - 1:39PM
18
Medicine
Five Chinese companies approved to make cheaper version of Pfizer’s Covid-19 oral drug
The five Chinese drug makers were among 35 firms to sign non-exclusive sublicensing agreements with the United Nations-backed MPP.
18 Mar 2022 - 9:00PM
5
India
Why are so many affluent Indian expats suddenly heading to Dubai?
Pfizer Covid shots, sparkling clean streets and tax-free policies are among the draws. And for investors with US$2.7 million to spare, there are ‘Golden Visas’, too.
6 Mar 2022 - 4:18PM
Coronavirus pandemic: All stories
Japan’s Covid-19 vaccine found ‘safe and effective’
Drug maker Shionogi is seeking regulatory approval as Japan currently relies on shots from Pfizer and Moderna; Covid-19 has already infected 5 million people in the country and killed more than 24,000.
4 Mar 2022 - 7:05PM
videocam
Coronavirus pandemic
BioNTech plans modular coronavirus vaccine factories in Africa
The German firm, which developed its Covid-19 shot with Pfizer, hopes to the move will make the jabs more widely available on the continent.
17 Feb 2022 - 2:59AM
Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement